Hyperion Defi (HYPD) Current Deferred Revenue (2020 - 2022)
Hyperion Defi (HYPD) posted quarterly Current Deferred Revenue of $28999.0 for Q3 2022, down 99.71% year-over-year from $10.0 million in Q3 2021, and up 5.6% quarter-over-quarter from $27462.0 in Q2 2022.
Hyperion Defi (HYPD) Current Deferred Revenue (2020 - 2022) Analysis & Trends
Hyperion Defi (HYPD) has reported Current Deferred Revenue for 3 consecutive years, with $28999.0 the latest figure, recorded in Q3 2022.
- In Q3 2022, Current Deferred Revenue fell 99.71% year-over-year to $28999.0; the TTM figure through Sep 2022 stood at $28999.0 (down 99.71% YoY), while the FY2021 annual figure was $18685.0, down 99.87% from the prior year.
- Current Deferred Revenue grew to $28999.0 in Q3 2022 per HYPD's latest filing, from $27462.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $14.0 million in Q4 2020 and bottomed at $6857.0 in Q1 2021.
- Historically, Current Deferred Revenue has averaged $3.1 million across 3 years, with a median of $27462.0 in 2022.
- Annual changes were most pronounced in 2021 — Current Deferred Revenue slumped 99.87% — and 2022, when it soared 300.5%.
- Hyperion Defi's Current Deferred Revenue stood at $14.0 million in 2020, then plunged by 99.87% to $18685.0 in 2021, then jumped by 55.2% to $28999.0 in 2022.
- Business Quant data shows HYPD's Current Deferred Revenue at $28999.0 in Q3 2022, $27462.0 in Q2 2022, and $23780.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - |
| 10 | Hyperion Defi | 46.21 Mn | 36.57 Mn | 357,693.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 28,999.00 |
| Jun 30, 2022 | 27,462.00 |
| Mar 31, 2022 | 23,780.00 |
| Dec 31, 2021 | 18,685.00 |
| Sep 30, 2021 | 10.00 Mn |
| Jun 30, 2021 | 6,857.00 |
| Mar 31, 2021 | 6,857.00 |
| Dec 31, 2020 | 14.00 Mn |
| Sep 30, 2020 | 4.00 Mn |